new glp-1 retatrutide 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 Phase 3 clinical results are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of Retatrutide — The Most Advanced

Be alert to specific GLP-1 medication red flags: severe, persistent abdominal pain (especially radiating to the back) with or without vomiting could indicate pancreatitis

Most hepatic improvements correlate with the degree of weight loss, with limited evidence for weight-independent antifibrotic effects

2018 RCT showed that 5 grams of specific collagen peptides per day led to measurable improvements in BMD over 12 months in postmenopausal women with reduced bone density

If you are experiencing noticeable puffiness, examine your food choices

Tirzepatide already covers GLP-1 (so semaglutide adds redundancy)

The gut produces a hormone called GLP-1, or glucagon-like peptide-1 when you eat